{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:27:39Z","timestamp":1787041659552,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004772","name":"Ningxia Hui Autonomous Region Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004772","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejmech.2026.119077","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:31:00Z","timestamp":1782257460000},"page":"119077","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Structure-based optimization of GSK2982772-derived RIPK1 inhibitors reveals the dispensability of the methylene linker and identifies a potent anti-necroptosis candidate for further optimization"],"prefix":"10.1016","volume":"317","author":[{"given":"Yanran","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengru","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojing","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongkang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9430-6152","authenticated-orcid":false,"given":"Ying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119077_bib1","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1056\/NEJMra0901217","article-title":"Cell death","volume":"361","author":"Hotchkiss","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.119077_bib2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nrm.2016.149","article-title":"Necroptosis in development, inflammation and disease","volume":"18","author":"Weinlich","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119077_bib3","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nrm2970","article-title":"Molecular mechanisms of necroptosis: an ordered cellular explosion","volume":"11","author":"Vandenabeele","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119077_bib4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.it.2016.06.002","article-title":"More to life than NF-\u03baB in TNFR1 signaling","volume":"37","author":"Ting","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ejmech.2026.119077_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41577-022-00792-3","article-title":"Death by TNF: a road to inflammation","volume":"23","author":"Van Loo","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2026.119077_bib6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2008.03.036","article-title":"TNF-\u03b1 induces two distinct Caspase-8 activation pathways","volume":"133","author":"Wang","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119077_bib7","doi-asserted-by":"crossref","first-page":"9505","DOI":"10.1074\/jbc.M109488200","article-title":"Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein (RIP) by RIP3","volume":"277","author":"Sun","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119077_bib8","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.cell.2009.05.037","article-title":"Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation","volume":"137","author":"Cho","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119077_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature14191","article-title":"Necroptosis and its role in inflammation","volume":"517","author":"Pasparakis","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119077_bib10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.tips.2016.12.005","article-title":"Complex pathologic roles of RIPK1 and RIPK3: moving beyond necroptosis","volume":"38","author":"Wegner","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2026.119077_bib11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","article-title":"Mixed Lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase","volume":"148","author":"Sun","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119077_bib12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.molcel.2014.03.003","article-title":"Mixed Lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3","volume":"54","author":"Wang","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2026.119077_bib13","doi-asserted-by":"crossref","first-page":"9714","DOI":"10.1073\/pnas.1901179116","article-title":"Targeting RIPK1 for the treatment of human diseases","volume":"116","author":"Degterev","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2026.119077_bib14","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1007\/s00415-021-10460-6","article-title":"Clinical course of central nervous system demyelinating neurological adverse events associated with anti-TNF therapy","volume":"268","author":"Cortese","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.ejmech.2026.119077_bib15","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nn738","article-title":"TNF\u03b1 promotes proliferation of oligodendrocyte progenitors and remyelination","volume":"4","author":"Arnett","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejmech.2026.119077_bib16","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41419-021-03994-0","article-title":"Antioxidant and food additive BHA prevents TNF cytotoxicity by acting as a direct RIPK1 inhibitor","volume":"12","author":"Delanghe","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.119077_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107979","article-title":"Novel insights into RIPK1 as a promising target for future Alzheimer's disease treatment","volume":"231","author":"Li","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2026.119077_bib18","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1042\/CS20181081","article-title":"A pan-RAF inhibitor LY3009120 inhibits necroptosis by preventing phosphorylation of RIPK1 and alleviates dextran sulfate sodium-induced colitis","volume":"133","author":"Zhang","year":"2019","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.ejmech.2026.119077_bib19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jdermsci.2020.06.001","article-title":"RIPK1: a rising star in inflammatory and neoplastic skin diseases","volume":"99","author":"Jin","year":"2020","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.ejmech.2026.119077_bib20","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1021\/jm901443h","article-title":"Through the \u201cGatekeeper door\u201d: exploiting the active kinase conformation","volume":"53","author":"Zuccotto","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119077_bib21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41419-017-0245-7","article-title":"RIPK1-dependent cell death: a novel target of the Aurora kinase inhibitor Tozasertib (VX-680)","volume":"9","author":"Martens","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.119077_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113947","article-title":"The Bcr-Abl inhibitor GNF-7 inhibits necroptosis and ameliorates acute kidney injury by targeting RIPK1 and RIPK3 kinases","volume":"177","author":"Qin","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119077_bib23","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1021\/acs.jmedchem.6b01751","article-title":"Discovery of a first-in-class receptor interacting protein 1 (RIP1) kinase specific clinical candidate (GSK2982772) for the treatment of inflammatory diseases","volume":"60","author":"Harris","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119077_bib24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.str.2013.01.016","article-title":"Structural basis of RIP1 inhibition by necrostatins","volume":"21","author":"Xie","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2026.119077_bib25","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1021\/acs.jmedchem.7b01647","article-title":"Discovery of 7-Oxo-2,4,5,7-tetrahydro-6 H -pyrazolo[3,4- c ]pyridine derivatives as potent, orally available, and brain-penetrating receptor interacting protein 1 (RIP1) kinase inhibitors: analysis of structure\u2013kinetic relationships","volume":"61","author":"Yoshikawa","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119077_bib26","doi-asserted-by":"crossref","first-page":"14971","DOI":"10.1021\/acs.jmedchem.2c01518","article-title":"Small-Molecule receptor-interacting protein 1 (RIP1) inhibitors as therapeutic agents for multifaceted diseases: current medicinal chemistry insights and emerging opportunities","volume":"65","author":"Shi","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119077_bib27","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.bmcl.2019.04.014","article-title":"Potent and selective inhibitors of receptor-interacting protein kinase 1 that lack an aromatic back pocket group","volume":"29","author":"Hamilton","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119077_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116304","article-title":"Scaffold hopping derived novel benzoxazepinone receptor-interacting protein kinase 1 (RIP1) inhibitors as anti-necroptosis agents: Anti-inflammatory effect in systemic inflammatory response syndrome (SIRS) and epilepsy","volume":"269","author":"Jiang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119077_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117385","article-title":"Scaffold hopping derived novel benzoxazepinone RIPK1 inhibitors as anti-necroptosis agents","volume":"91","author":"Tang","year":"2023","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119077_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108365","article-title":"Discovery of a novel quinoline RIP1 inhibitor and its treatment of acute liver injury in mice","volume":"159","author":"Xu","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119077_bib31","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41573-024-00942-3","article-title":"The state of the art in secondary pharmacology and its impact on the safety of new medicines","volume":"23","author":"Brennan","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119077_bib32","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s13555-024-01097-0","article-title":"Inhibition of receptor-interacting protein kinase 1 in chronic plaque psoriasis: a multicenter, randomized, Double-Blind, placebo-controlled Study","volume":"14","author":"Ludbrook","year":"2024","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.ejmech.2026.119077_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2021-000680","article-title":"A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis","volume":"8","author":"Weisel","year":"2021","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.ejmech.2026.119077_bib34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13075-021-02468-0","article-title":"A randomized, placebo-controlled experimental medicine study of RIPK1 inhibitor GSK2982772 in patients with moderate to severe rheumatoid arthritis","volume":"23","author":"Weisel","year":"2021","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejmech.2026.119077_bib35","article-title":"Potent and selective RIPK1 inhibitors targeting dual\u2010pockets for the treatment of systemic inflammatory response syndrome and sepsis","volume":"61","author":"Yang","year":"2022","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2026.119077_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106964","article-title":"Discovery of novel 5-phenylpyrazol receptor interacting protein 1(RIP1) kinase inhibitors as anti-necroptosis agents by combining virtual screening and in vitro and in vivo experimental evaluations","volume":"142","author":"Shi","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119077_bib37","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.immuni.2011.09.020","article-title":"RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome","volume":"35","author":"Duprez","year":"2011","journal-title":"Immunity"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:02:54Z","timestamp":1787040174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426005222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":37,"alternative-id":["S0223523426005222"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119077","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-based optimization of GSK2982772-derived RIPK1 inhibitors reveals the dispensability of the methylene linker and identifies a potent anti-necroptosis candidate for further optimization","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119077"}}